SILO 8-K 2026-11-06

Silo Pharma, Inc. (SILO) 8-K dated 2026-11-06 — accession 0001213900-26-116982.

Silo Pharma, Inc. (SILO) is a biotechnology company listed on US.

Silo Pharma, Inc. filed a 8-K on 2026-11-06. Accession 0001213900-26-116982.

This 8-K covers: Material agreement (Item 1.01), Unregistered share sale (Item 3.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported SILO revenue for 2025-12-31 was $72.1K. Net income was -$4.2M. Revenue was up 0.0% from 2024-12-31 to 2025-12-31. SILO currently screens at market cap $4.4M.

Not investment advice. The SILO SEC hub lists recent forms. The stock page is the research view.